Delivery Order SPE2DB22D9239-SPE2DB24FDM69

Award Date 9/18/24
Potential Completion Date 10/9/24
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a $26,575.14 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract awarded to DMS Pharmaceutical Group by DLA under the SPE2DB program, which provides a...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $26,575.14 contract is for the delivery of ILARIS 150 MG/ML VIALML, with a completion date of February 29, 2024. DMS Pharmaceutical Group holds a larger indefinite-delivery contract, valued up to $4,999,999, with the Defense Logistics Agency under the SPE2DB program. This single-award...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a comprehensive range of...
This is a firm fixed-price delivery order (SPE2DB25FX1LH) awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $26,575.14 and covers the delivery of ILARIS 150 MG/ML vial, a specialized pharmaceutical product, with a completion date of November 26, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,254.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that the DLA awarded to DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products, including common medications, specialized drugs, and...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract valued at $68,439.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an ultimate completion date of October 2, 2024, is for the delivery of a variety of pharmaceutical products, including medications, biologics, and medical supplies, to support the recurring medical needs of military health...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $1,446.17, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which provides for the supply of a comprehensive range of pharmaceutical products, including common...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,928.68, is for the provision of a variety of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,347.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of various pharmaceutical products and medical supplies to support the medical supply needs of military health facilities nationwide. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,412.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract, with a period of performance through August 7, 2024, is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that the DLA has with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products, including...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDM69
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $39,862.71 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the medication ILARIS 150 MG/ML VIALML and has an ultimate completion date of October 9, 2024.

DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current delivery order is not set-aside and is being awarded directly to DMS Pharmaceutical Group Inc. as a woman-owned small business supplier supporting the DLA's Medical Supply Chain division.

Generated 12/18/24, 9:39 AM